Given that IKKβ is a chief positive regulator of canonical NF-κB, these findings provide further support for the theory that NF-κB activation may be blunted in people with schizophrenia compared to what a ‘normal’ response to increased brain cytokines would be. This evidence concerns the gene NFKB1 and schizophrenia.